Search Within

Michael Zaidinski

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (4)
Groups
  1. Department of Pathology and Laboratory Medicine (10)
  2. Human Oncology and Pathogenesis Program (10)
  3. Tow Center for Developmental Oncology (TCDO) (10)
  4. GSK Faculty (8)
  5. Department of Medicine (4)
  6. Center for Hematologic Malignancies (2)

More Groups

People
  1. Marc Ladanyi (8)
  2. Khedoudja Nafa (6)
  3. Maria Arcila (5)
  4. Snjezana Dogan (4)
  5. Dara Ross (3)
  6. Kerry Mullaney (3)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2019 (1)
  4. 2015 (2)
  5. 2014 (1)
  6. 2012 (1)
Publications
  1. Journal of Molecular Diagnostics (5)
  2. Clinical Cancer Research (1)
  3. Genes Chromosomes and Cancer (1)
  4. Histopathology (1)
  5. Molecular Cancer Research (1)
  6. Virchows Archiv (1)
Publishers
  1. Elsevier Science, Inc. (5)
  2. American Association for Cancer Research (2)
  3. Springer (1)
  4. Wiley Blackwell (1)
  5. Wiley Periodicals, Inc (1)

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeted RNA sequencing in diagnostically challenging head and neck carcinomas identifies novel MON2::STAT6, NFATC2::NUTM2B, POC5::RAF1, and NSD3::NCOA2 gene fusions
    Journal Article

    Chu, Y. H.; Katabi, N.; Sukhadia, P.; Mullaney, K. A.; Zaidinski, M.; Cracchiolo, J. R.; Xu, B.; Ghossein, R. A.; Ho, A. L.; DiNapoli, S. E.; more...
    Histopathology (2025)

    Fulltext@MSK | Save
  • A novel JAK2 fusion in T-cell prolymphocytic leukemia
    Meeting Abstract

    Eren, O. C.; Stuver, R.; Zhou, T.; Zaidinski, M.; Moskowitz, A. J.; Horwitz, S. M.; Ewalt, M. D.; Zhang, Y.; Lim, M.
    Virchows Archiv (2024)

    Fulltext@MSK | Save
  • Correction of small bias for clinically relevant CpG sites interrogated by the updated EPICv2/900K methylation array
    Meeting Abstract

    Aldyab, M.; Upadhyayula, N.; Borsu, L.; Nafa, K.; Villafania, L.; Zaidinski, M.; Mullhaney, K.; Bale, T.; Arcila, M.; Ladanyi, M.; more...
    Journal of Molecular Diagnostics (2024)

    Fulltext@MSK | Save
  • A novel JAK2 fusion in T-cell prolymphocytic leukemia
    Journal Article

    Eren, O. C.; Stuver, R.; Zhou, T.; Zaidinski, M.; Moskowitz, A. J.; Horwitz, S. M.; Ewalt, M. D.; Zhang, Y.; Lim, M. S.
    Genes Chromosomes and Cancer (2024)

    Fulltext@MSK | Save
  • Impact of rare and multiple concurrent gene fusions on diagnostic DNA methylation classifier in brain tumors
    Journal Article

    Galbraith, K.; Serrano, J.; Shen, G.; Tran, I.; Slocum, C. C.; Ketchum, C.; Abdullaev, Z.; Turakulov, R.; Bale, T.; Ladanyi, M.; more...
    Molecular Cancer Research (2024)

    Fulltext@MSK | Save
  • Validation and implementation of ultra-rapid mutation and MSI assessment using the Idylla platform
    Meeting Abstract

    Nafa, K.; Momeni Boroujeni, A.; Gandia, E.; Solomon, J. P.; Vakiani, E.; Zhu, M.; Chan, R.; Elezovic, D.; Mensah, N. T.; Rijo, I.; more...
    Journal of Molecular Diagnostics (2019)

    Fulltext@MSK | Save
  • Benefits and challenges of next generation sequencing in routine assessment of myeloid neoplasms: MSKCC two-year experience
    Meeting Abstract

    Middha, S.; Zaidinski, M.; Son, J.; Mohanty, A.; Zehir, A.; Cheng, D.; Nafa, K.; Benayed, R.; Jour, G.; Tian, S.; more...
    Journal of Molecular Diagnostics (2015)

    Fulltext@MSK | Save
  • Clinical monitoring of patients with myeloid malignancies using targeted next-generation sequencing
    Meeting Abstract

    Mohanty, A.; Zaidinski, M.; Son, J.; Zehir, A.; Middha, S.; Cheng, D. T.; Jour, G.; Tian, S. K.; DeLair, D.; Sadri, N.; more...
    Journal of Molecular Diagnostics (2015)

    Fulltext@MSK | Save
  • Comprehensive, targeted, multi-gene testing for risk stratification and clinical management of myeloid neoplasms
    Meeting Abstract

    Arcila, M. E.; Oultache, A.; Anna, P.; Zaidinski, M.; Sadowska, J.; Casanova, J.; Zha, Z.; Benayed, R.; Nafa, K.; Hameed, M.; more...
    Journal of Molecular Diagnostics (2014)

    Fulltext@MSK | Save
  • Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas
    Journal Article

    Arcila, M. E.; Chaft, J. E.; Nafa, K.; Roy Chowdhuri, S.; Lau, C.; Zaidinski, M.; Paik, P. K.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save